Clinical Trials Browser

Phase 2 × NIH × dolastatin 10 × Clear all

NCT00005579 2013-06-26

Dolastatin 10 in Treating Patients With Indolent Lymphoma, Waldenstrom's Macroglobulinemia, or Chronic Lymphocytic Leukemia

Phase 2 Completed

LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Leukemia, Lymphocytic, Chronic, B-Cell

NCT00003778 2013-02-08

Dolastatin 10 in Treating Patients With Recurrent or Metastatic Soft Tissue Sarcoma

Phase 2 Completed

GynecologicSarcoma

Ovarian Neoplasms, Sarcoma